Trials / Active Not Recruiting
Active Not RecruitingNCT05235516
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate AK104 Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 636 (estimated)
- Sponsor
- Akeso · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the efficacy and safety of AK104 plus concurrent chemoradiotherapy compared to placebo plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AK104 | q3w iv |
| RADIATION | EBRT | 45-50.4Gy |
| RADIATION | BT | ≥80Gy |
| DRUG | cisplatin | qw iv |
| DRUG | Placebo | q3w iv |
Timeline
- Start date
- 2022-06-21
- Primary completion
- 2026-05-01
- Completion
- 2029-05-01
- First posted
- 2022-02-11
- Last updated
- 2024-08-13
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05235516. Inclusion in this directory is not an endorsement.